My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.

    Schooley RT, Merigan TC, Gaut P, Hirsch MS, Holodniy M, Flynn T, Liu S, Byington RE, Henochowicz S, Gubish E, et al.

    Ann Intern Med. 1990 Feb 15;112(4):247-53.PMID: 2297203 [PubMed - indexed for MEDLINE]Related articles

    2.

    The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

    Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al.

    Ann Intern Med. 1990 Feb 15;112(4):254-61.PMID: 2297204 [PubMed - indexed for MEDLINE]Related articles

    3.

    Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex.

    Hodges TL, Kahn JO, Kaplan LD, Groopman JE, Volberding PA, Amman AJ, Arri CJ, Bouvier LM, Mordenti J, Izu AE, et al.

    Antimicrob Agents Chemother. 1991 Dec;35(12):2580-6.PMID: 1810192 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.

    Schacker T, Collier AC, Coombs R, Unadkat JD, Fox I, Alam J, Wang JP, Eggert E, Corey L.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):145-52.PMID: 7749791 [PubMed - indexed for MEDLINE]Related articles

    5.

    Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.

    Miles SA, Wang HJ, Cortes E, Carden J, Marcus S, Mitsuyasu RT.

    Ann Intern Med. 1990 Apr 15;112(8):582-9.PMID: 2109563 [PubMed - indexed for MEDLINE]Related articles

    6.

    Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.

    Collier AC, Coombs RW, Katzenstein D, Holodniy M, Gibson J, Mordenti J, Izu AE, Duliege AM, Ammann AJ, Merigan T, et al.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):150-6.PMID: 7552478 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.

    Crumpacker C, Heagy W, Bubley G, Monroe JE, Finberg R, Hussey S, Schnipper L, Lucey D, Lee TH, McLane MF, et al.

    Ann Intern Med. 1987 Nov;107(5):664-74.PMID: 3662279 [PubMed - indexed for MEDLINE]Related articles

    8.

    Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.

    Merigan TC, Skowron G, Bozzette SA, Richman D, Uttamchandani R, Fischl M, Schooley R, Hirsch M, Soo W, Pettinelli C, et al.

    Ann Intern Med. 1989 Feb 1;110(3):189-94.PMID: 2536257 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

    Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gorter R, Ueno R.

    Ann Intern Med. 1989 Feb 1;110(3):183-8.PMID: 2463780 [PubMed - indexed for MEDLINE]Related articles

    10.

    2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.

    Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, et al.

    N Engl J Med. 1990 May 10;322(19):1333-40.PMID: 2139173 [PubMed - indexed for MEDLINE]Related articles

    11.

    High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

    Daar ES, Li XL, Moudgil T, Ho DD.

    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8.PMID: 2395859 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.

    Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE.

    Am J Med. 1991 Nov;91(5):471-8.PMID: 1659189 [PubMed - indexed for MEDLINE]Related articles

    13.

    Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection.

    Husson RN, Chung Y, Mordenti J, Butler KM, Chen S, Duliege AM, Brouwers P, Jarosinski P, Mueller BU, Ammann A, et al.

    J Pediatr. 1992 Oct;121(4):627-33.PMID: 1357124 [PubMed - indexed for MEDLINE]Related articles

    14.

    The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.

    Yarchoan R, Mitsuya H, Pluda JM, Marczyk KS, Thomas RV, Hartman NR, Brouwers P, Perno CF, Allain JP, Johns DG, et al.

    Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S522-33.PMID: 1974724 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex.

    Pialoux G, Youle M, Dupont B, Gazzard B, Cauwenbergh GF, Stoffels PA, Davies S, de Saint Martin J, Janssen PA.

    Lancet. 1991 Jul 20;338(8760):140-3.PMID: 1677064 [PubMed - indexed for MEDLINE]Related articles

    16.

    Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.

    Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA.

    N Engl J Med. 1990 May 10;322(19):1340-5.PMID: 2139174 [PubMed - indexed for MEDLINE]Related articles

    17.

    Didanosine in the treatment of AIDS and AIDS-related complex: a critical appraisal of the dose and frequency of administration.

    Liebman HA, Cooley TP.

    Clin Infect Dis. 1993 Feb;16 Suppl 1:S52-8.PMID: 8093847 [PubMed - indexed for MEDLINE]Related articles

    18.

    A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS.

    Ho M, Armstrong J, McMahon D, Pazin G, Huang XL, Rinaldo C, Whiteside T, Tripoli C, Levine G, Moody D, et al.

    Blood. 1993 Apr 15;81(8):2093-101.PMID: 8471768 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

    Merigan TC, Skowron G.

    Am J Med. 1990 May 21;88(5B):11S-15S. Review.PMID: 2159703 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.

    Krown SE, Aeppli D, Balfour HH Jr.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):245-54.PMID: 10077172 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity